{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T04:12:45Z","timestamp":1788581565817,"version":"build-2803163510"},"reference-count":27,"publisher":"Japan Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1507\/endocrj.ej26-0108","type":"journal-article","created":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T22:10:40Z","timestamp":1778537440000},"page":"1069-1079","source":"Crossref","is-referenced-by-count":0,"title":["Anti\u2013pituitary-specific transcription factor-1 hypophysitis developing after thymoma resection: a case report with review of literature"],"prefix":"10.1507","volume":"73","author":[{"given":"Hitomi","family":"Konishi","sequence":"first","affiliation":[{"name":"Department of Diabetes and Endocrinology, Osaka City General Hospital, Osaka 534-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7722-4211","authenticated-orcid":false,"given":"Yui","family":"Yamashita","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Osaka City General Hospital, Osaka 534-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9889-9672","authenticated-orcid":false,"given":"Yuma","family":"Motomura","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7996-232X","authenticated-orcid":false,"given":"Shin","family":"Urai","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumiko","family":"Sasai","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Osaka City General Hospital, Osaka 534-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9099-7673","authenticated-orcid":false,"given":"Keiko","family":"Yamagami","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Osaka City General Hospital, Osaka 534-0021, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7421-2714","authenticated-orcid":false,"given":"Hironori","family":"Bando","sequence":"additional","affiliation":[{"name":"Division of Diabetes and Endocrinology, Department of Internal Medicine, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4541-0981","authenticated-orcid":false,"given":"Naotetsu","family":"Kanamoto","sequence":"additional","affiliation":[{"name":"Department of Diabetes and Endocrinology, Osaka City General Hospital, Osaka 534-0021, Japan"},{"name":"Division of Endocrinology and Metabolism, National Hospital Organization Kyoto Medical Center, Kyoto 612-8555, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1 Ingraham HA, Chen RP, Mangalam HJ, Elsholtz HP, Flynn SE, et al. (1988) A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 55: 519\u2013529.","DOI":"10.1016\/0092-8674(88)90038-4"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2 Cohen LE, Wondisford FE, Radovick S (1996) Role of Pit-1 in the gene expression of growth hormone, prolactin, and thyrotropin. Endocrinol Metab Clin North Am 25: 523\u2013540.","DOI":"10.1016\/S0889-8529(05)70339-X"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3 Yamamoto M, Iguchi G, Takeno R, Okimura Y, Sano T, et al. (2011) Adult combined GH, prolactin, and TSH deficiency associated with circulating PIT-1 antibody in humans. J Clin Invest 121: 113\u2013119.","DOI":"10.1172\/JCI44073"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Yamamoto M, Iguchi G, Bando H, Kanie K, Hidaka-Takeno R, et al. (2020) Autoimmune pituitary disease: new concepts with clinical implications. Endocr Rev 41: bnz003.","DOI":"10.1210\/endrev\/bnz003"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Takahashi Y (2023) Paraneoplastic autoimmune hypophysitis: a novel form of paraneoplastic endocrine syndrome. Endocr J 70: 559\u2013565.","DOI":"10.1507\/endocrj.EJ23-0050"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Bando H, Iguchi G, Okimura Y, Odake Y, Yoshida K, et al. (2017) A novel thymoma-associated autoimmune disease: Anti-PIT-1 antibody syndrome. Sci Rep 7: 43060.","DOI":"10.1038\/srep43060"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Kanie K, Iguchi G, Inuzuka M, Sakaki K, Bando H, et al. (2021) Two cases of anti-PIT-1 hypophysitis exhibited as a form of paraneoplastic syndrome not associated with thymoma. J Endocr Soc 5: bvaa194.","DOI":"10.1210\/jendso\/bvaa194"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Urai S, Iguchi G, Kanie K, Bando H, Yamamoto M, et al. (2024) Clinical features of anti-pituitary-specific transcription factor-1 (PIT-1) hypophysitis: a new aspect of paraneoplastic autoimmune condition. Eur J Endocrinol 190: K1\u2013K7.","DOI":"10.1093\/ejendo\/lvad179"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9 Urai S, Tomofuji S, Bando H, Kanzawa M, Yamamoto M, et al. (2024) The early-stage clinical course of anti-pituitary-specific transcription factor-1 hypophysitis diagnosed post-immune checkpoint inhibitor treatment: a case with review of literature. J Neuroendocrinol 36: e13395.","DOI":"10.1111\/jne.13395"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Fleseriu M, Hashim IA, Karavitaki N, Melmed S, Murad MH, et al. (2016) Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 101: 3888\u20133921.","DOI":"10.1210\/jc.2016-2118"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Chihara K, Shimatsu A, Hizuka N, Tanaka T, Seino Y, et al. (2007) A simple diagnostic test using GH-releasing peptide-2 in adult GH deficiency. Eur J Endocrinol 157: 19\u201327.","DOI":"10.1530\/EJE-07-0066"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Kanda Y (2013) Investigation of the freely available easy-to-use software \u2018EZR\u2019 for medical statistics. Bone Marrow Transplant 48: 452\u2013458.","DOI":"10.1038\/bmt.2012.244"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Brunn J, Block U, Ruf G, Bos I, Kunze WP, et al. (1981) Volumetric analysis of thyroid lobes by real-time ultrasound. Dtsch Med Wochenschr 106: 1338\u20131340 (in German).","DOI":"10.1055\/s-2008-1070506"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Isojima T, Shimatsu A, Yokoya S, Chihara K, Tanaka T, et al. (2012) Standardized centile curves and reference intervals of serum insulin-like growth factor-I (IGF-I) levels in a normal Japanese population using the LMS method. Endocr J 59: 771\u2013780.","DOI":"10.1507\/endocrj.EJ12-0110"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Heaney AP, Sumerel B, Rajalingam R, Bergsneider M, Yong WH, et al. (2015) HLA Markers DQ8 and DR53 are associated with lymphocytic hypophysitis and may aid in differential diagnosis. J Clin Endocrinol Metab 100: 4092\u20134097.","DOI":"10.1210\/jc.2015-2702"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Alvarenga MP, do Carmo LF, Vasconcelos CCF, Alvarenga MP, Alvarenga-Filho H, et al. (2021) Neuromyelitis optica is an HLA associated disease different from Multiple Sclerosis: a systematic review with meta-analysis. Sci Rep 11: 152.","DOI":"10.1038\/s41598-020-80535-3"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Pisetsky DS (2023) Pathogenesis of autoimmune disease. Nat Rev Nephrol 19: 509\u2013524.","DOI":"10.1038\/s41581-023-00720-1"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Zhai J, Gu X, Liu Y, Hu Y, Jiang Y, et al. (2023) Chemotherapeutic and targeted drugs-induced immunogenic cell death in cancer models and antitumor therapy: an update review. Front Pharmacol 14: 1152934.","DOI":"10.3389\/fphar.2023.1152934"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Kroemer G, Galassi C, Zitvogel L, Galluzzi L (2022) Immunogenic cell stress and death. Nat Immunol 23: 487\u2013500.","DOI":"10.1038\/s41590-022-01132-2"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Caballero-Herrero MJ, Jumilla E, Buitrago-Ruiz M, Valero-Navarro G, Cuevas S (2023) Role of damage-associated molecular patterns (DAMPS) in the postoperative period after colorectal surgery. Int J Mol Sci 24: 3862.","DOI":"10.3390\/ijms24043862"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Kaltenmeier C, Wang R, Popp B, Geller D, Tohme S, et al. (2022) Role of immuno-inflammatory signals in liver ischemia-reperfusion injury. Cells 11: 2222.","DOI":"10.3390\/cells11142222"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kondo K, Monden Y (2005) Myasthenia gravis appearing after thymectomy for thymoma. Eur J Cardiothorac Surg 28: 22\u201325.","DOI":"10.1016\/j.ejcts.2005.03.039"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Kim A, Choi SJ, Kang CH, Lee S, Son H, et al. (2021) Risk factors for developing post-thymectomy myasthenia gravis in patients with thymoma. Muscle Nerve 63: 531\u2013537.","DOI":"10.1002\/mus.27169"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Lin TM, Chang YS, Hou TY, Hsu HC, Lin SH, et al. (2020) Risk of incident autoimmune diseases in patients with thymectomy. Ann Clin Transl Neurol 7: 1072\u20131082.","DOI":"10.1002\/acn3.51055"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Kooshesh KA, Foy BH, Sykes DB, Gustafsson K, Scadden DT (2023) Health consequences of thymus removal in adults. N Engl J Med 389: 406\u2013417.","DOI":"10.1056\/NEJMoa2302892"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Tsirkin I, Khateb M, Aran D, Kaz A, Shelly S (2025) Survival and autoimmune risks post-thymectomy. Front Immunol 16: 1504496.","DOI":"10.3389\/fimmu.2025.1504496"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Kanie K, Ito T, Iguchi G, Matsumoto R, Muguruma K, et al. (2025) Modeling of T cell-mediated autoimmune pituitary disease using human induced pluripotent stem cell-originated organoid. Nat Commun 16: 7900.","DOI":"10.1038\/s41467-025-63183-x"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/9\/73_EJ26-0108\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T03:38:24Z","timestamp":1788579504000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/73\/9\/73_EJ26-0108\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej26-0108","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"article-number":"EJ26-0108"}}